Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlookLena Horvath, Andreas Pircher|Molecular Cancer|2020Cited by 300
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancerIsabel Heidegger, Andreas Pircher|Molecular Cancer|2022Cited by 177